Option Care Health (OPCH) Tops Q2 EPS by 2c, provides guidance

Option Care Health (NASDAQ: OPCH) reported Q2 EPS of $0.30, $0.02 better than the analyst estimate of $0.28. Revenue for the quarter came in at $1.23 billion versus the consensus estimate of $1.17 billion.

GUIDANCE:

Option Care Health sees FY2024 revenue of $4.75-4.85 billion, versus the consensus of $4.753 billion.
Adjusted EBITDA of $435 million to $450 million
Cash flow from operations of at least $300 million, consistent with previous guidance
Effective tax rate of 26% - 28%, consistent with previous guidance
Net interest expense of approximately $55 million to $60 million, consistent with previous guidance

For earnings history and earnings-related data on Option Care Health (OPCH) click here.

You May Also Be Interested In

• Citrini flags overheating concerns as leverage, chip rally weigh on KOSPI
• Daiwa Securities Downgrades JD.com, Inc (JD) to Hold
• RBC initiates GE HealthCare as it sees AI-led innovation cycle driving growth